PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
23-Jul-2024 ViroCell Biologics signs Master Services Agreement with prominent NCI-designated cancer center ViroCell
23-Jul-2024 ViiV Healthcare announces positive data demonstrating 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy for maintenance therapy of HIV-1 ViiV Healthcare
23-Jul-2024 ViiV Healthcare announces positive new data for Apretude use during pregnancy at AIDS 2024 ViiV Healthcare
23-Jul-2024 ViiV Healthcare premieres early data showing antiviral activity against integrase resistance from its investigational, third-generation integrase inhibitor AIDS 2024 ViiV Healthcare
23-Jul-2024 Xeltis appoints Shawn Gage as Vice President of US Clinical Affairs Xeltis
22-Jul-2024 Avista Capital Partners and Hamilton Lane Announce Partnership in Cosette Pharmaceuticals Avista Capital Partners
22-Jul-2024 Transgene and BioInvent to Present Poster on Oncolytic Virus, BT-001, at ESMO 2024 Transgene
22-Jul-2024 Certa Therapeutics Receives EU Orphan Designation for FT011, a GPR68 Inhibitor Being Developed as an Anti-Fibrotic Treatment for Systemic Sclerosis Certa Therapeutics
22-Jul-2024 APOLLO THERAPEUTICS AND THE UNIVERSITY OF OXFORD ENTER INTO DRUG DISCOVERY AND DEVELOPMENT COLLABORATION Apollo Therapeutics
22-Jul-2024 Research reveals the greatest fear of life sciences tech leaders: cyber espionage NTT DATA
22-Jul-2024 Pioneering biotech extends collaboration with leading global drug researcher to boost search for rare disease therapies SynaptixBio
22-Jul-2024 APOLLO THERAPEUTICS AND THE UNIVERSITY OF OXFORD ENTER INTO DRUG DISCOVERY AND DEVELOPMENT COLLABORATION Apollo Therapeutics
22-Jul-2024 Pioneering biotech extends collaboration with leading global drug researcher to boost search for rare disease therapies SynaptixBio
17-Jul-2024 Genomics plc Announces New Extension and Expansion of Drug Discovery Collaboration with Vertex Genomics plc
17-Jul-2024 Velocity appoints ex-IQVIA and Science 37 Executive Mike Zaranek as CFO Velocity Clinical Research
17-Jul-2024 ALZpath Signs Licensing Agreement with Beckman Coulter Diagnostics to Provide Proprietary pTau217 Antibody to Develop a Diagnostic Blood Test for Alzheimer’s Disease ALZpath
17-Jul-2024 Nouscom Appoints Tiffany Muller as Chief Financial Officer and Loredana Siani as Senior Vice President, Technical and CMC Development Nouscom
17-Jul-2024 4SC receives Orphan Drug Status (ODS) for resminostat (Kinselby) in cutaneous T-cell lymphoma in Switzerland 4SC
17-Jul-2024 Dr Gloria Gonzalez-Aseguinolaza, Chief Scientific Officer of Vivet Therapeutics Receives the Rosalind Franklin Society Special Award in Science Vivet Therapeutics
17-Jul-2024 Asceneuron Secures $100 Million Series C Financing to Advance Groundbreaking Therapeutics in Neurodegenerative Diseases Asceneuron